KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Total Liabilities (2016 - 2026)

Xylem has reported Total Liabilities over the past 17 years, most recently at $5.7 billion for Q1 2026.

  • For Q1 2026, Total Liabilities rose 4.0% year-over-year to $5.7 billion; the TTM value through Mar 2026 reached $5.7 billion, up 4.0%, while the annual FY2025 figure was $5.9 billion, 4.88% up from the prior year.
  • Total Liabilities for Q1 2026 was $5.7 billion at Xylem, down from $5.9 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $6.2 billion in Q2 2023 and troughed at $4.4 billion in Q1 2023.
  • A 5-year average of $5.5 billion and a median of $5.6 billion in 2024 define the central range for Total Liabilities.
  • On a YoY basis, Total Liabilities climbed as much as 33.42% in 2023 and fell as far as 13.21% in 2023.
  • Year by year, Total Liabilities stood at $4.4 billion in 2022, then soared by 33.42% to $5.9 billion in 2023, then decreased by 5.48% to $5.6 billion in 2024, then increased by 4.88% to $5.9 billion in 2025, then dropped by 2.72% to $5.7 billion in 2026.
  • Business Quant data shows Total Liabilities for XYL at $5.7 billion in Q1 2026, $5.9 billion in Q4 2025, and $5.9 billion in Q3 2025.